Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR56A1 Inhibitors

OR56A1 belongs to the olfactory receptor family, a group of G-protein coupled receptors (GPCRs) that play a pivotal role in the detection of odorants and the initiation of olfactory signal transduction. The expression of the OR56A1 protein is a highly regulated process, as with many GPCRs, involving a complex interplay between transcriptional, post-transcriptional, and epigenetic mechanisms. Understanding the regulation of OR56A1 is of interest to researchers studying olfaction and the broad mechanisms that govern the expression of sensory receptors. OR56A1's expression is tightly controlled by the cellular machinery to ensure precise olfactory function, and any deviation in its expression can potentially alter olfactory perception. Scientists have identified a range of chemical compounds that could inhibit the expression of the OR56A1 protein. These inhibitors operate through diverse mechanisms to silence or suppress the activity of the gene encoding OR56A1. For example, histone deacetylase inhibitors such as Trichostatin A and Valproic Acid could modify the chromatin structure at the OR56A1 gene locus, leading to a more condensed state that is not conducive to gene transcription. DNA methylation agents like 5-Azacytidine could potentially induce DNA demethylation, which in turn could attract repressive transcription machinery that silences OR56A1 gene expression. Other chemicals may interfere with the transcriptional activation of the OR56A1 gene; for instance, Retinoic acid could block the recruitment of transcription factors necessary for OR56A1 expression by binding to their receptors. Inhibitors of signaling pathways, such as LY294002 and PD98059, could impede the pathways that promote OR56A1 expression, leading to reduced transcriptional activity. Each inhibitor's effect on OR56A1 expression is subject to the specific context of the olfactory receptor cells and the broader physiological state. Consequently, the degree to which these chemicals inhibit OR56A1 expression would need to be quantified through precise and controlled scientific experiments.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

By inhibiting histone deacetylase, this compound could lead to hyperacetylation of histones, which may result in the condensed chromatin around the OR56A1 gene, thereby silencing its transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This cytidine analog could cause DNA demethylation at the OR56A1 gene locus, which might lead to the recruitment of repressive transcriptional machinery and subsequent transcriptional silencing of the gene.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

As an inhibitor of histone deacetylase, Valproic Acid could promote a chromatin state around the OR56A1 gene that represses transcription, effectively downregulating gene expression.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

By depleting the pool of methyl donors through dihydrofolate reductase inhibition, Methotrexate could lead to hypomethylation of the OR56A1 gene promoter, potentially resulting in the binding of repressor complexes that silence the gene.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

This compound could bind retinoic acid receptors that, when not activated, recruit co-repressors to the OR56A1 gene promoter, leading to transcriptional repression.

Vinclozolin

50471-44-8sc-251425
250 mg
$23.00
1
(1)

As a fungicide with anti-androgenic effects, Vinclozolin could disrupt the normal hormonal regulation, potentially attenuating the androgen-mediated transcriptional activation of the OR56A1 gene.

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$63.00
$265.00
21
(1)

This antifungal agent can inhibit steroidogenesis, reducing the synthesis of steroid hormones that may be necessary for the upregulation of the OR56A1 gene, resulting in its decreased expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

By inhibiting mTOR, Rapamycin (Sirolimus) could lead to a general decrease in cap-dependent mRNA translation, which would include a reduction in the synthesis of the OR56A1 protein.

Chloramphenicol

56-75-7sc-3594
25 g
$90.00
10
(1)

Its function as a bacterial protein synthesis inhibitor could, in theory, reduce the translation of mRNAs in eukaryotic mitochondria, potentially diminishing the cellular components necessary for OR56A1 expression.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Through the inhibition of RNA polymerase II, Alpha-amanitin could suppress the transcription of the OR56A1 gene, leading to a decrease in mRNA and protein levels.